Withholding direct thrombin inhibitor therapy while awaiting laboratory confirmation of heparin-induced thrombocytopenia is associated with an increased rate of thromboembolic complications: Results of the complications after thrombocytopenia caused by heparin (CATCH) registry
Publication
, Conference
Rodgers, JE; Anstrom, KJ; Honeycutt, EF; Abrams, CS; Becker, RC; Berger, PB; Crespo, EM; Moliterno, DJ; Moll, S; Rice, L; Steinhubl, SR ...
Published in: CIRCULATION
October 26, 2004
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
October 26, 2004
Volume
110
Issue
17
Start / End Page
371 / 371
Location
New Orleans, LA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
77th Scientific Meeting of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Rodgers, J. E., Anstrom, K. J., Honeycutt, E. F., Abrams, C. S., Becker, R. C., Berger, P. B., … Ohman, E. M. (2004). Withholding direct thrombin inhibitor therapy while awaiting laboratory confirmation of heparin-induced thrombocytopenia is associated with an increased rate of thromboembolic complications: Results of the complications after thrombocytopenia caused by heparin (CATCH) registry. In CIRCULATION (Vol. 110, pp. 371–371). New Orleans, LA: LIPPINCOTT WILLIAMS & WILKINS.
Rodgers, J. E., K. J. Anstrom, E. F. Honeycutt, C. S. Abrams, R. C. Becker, P. B. Berger, E. M. Crespo, et al. “Withholding direct thrombin inhibitor therapy while awaiting laboratory confirmation of heparin-induced thrombocytopenia is associated with an increased rate of thromboembolic complications: Results of the complications after thrombocytopenia caused by heparin (CATCH) registry.” In CIRCULATION, 110:371–371. LIPPINCOTT WILLIAMS & WILKINS, 2004.
Rodgers JE, Anstrom KJ, Honeycutt EF, Abrams CS, Becker RC, Berger PB, et al. Withholding direct thrombin inhibitor therapy while awaiting laboratory confirmation of heparin-induced thrombocytopenia is associated with an increased rate of thromboembolic complications: Results of the complications after thrombocytopenia caused by heparin (CATCH) registry. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2004. p. 371–371.
Rodgers, J. E., et al. “Withholding direct thrombin inhibitor therapy while awaiting laboratory confirmation of heparin-induced thrombocytopenia is associated with an increased rate of thromboembolic complications: Results of the complications after thrombocytopenia caused by heparin (CATCH) registry.” CIRCULATION, vol. 110, no. 17, LIPPINCOTT WILLIAMS & WILKINS, 2004, pp. 371–371.
Rodgers JE, Anstrom KJ, Honeycutt EF, Abrams CS, Becker RC, Berger PB, Crespo EM, Moliterno DJ, Moll S, Rice L, Steinhubl SR, Tapson VF, Ohman EM. Withholding direct thrombin inhibitor therapy while awaiting laboratory confirmation of heparin-induced thrombocytopenia is associated with an increased rate of thromboembolic complications: Results of the complications after thrombocytopenia caused by heparin (CATCH) registry. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2004. p. 371–371.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
October 26, 2004
Volume
110
Issue
17
Start / End Page
371 / 371
Location
New Orleans, LA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
77th Scientific Meeting of the American-Heart-Association
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology